{
  "id": "d4aef731c6d8a24e",
  "title": "FDA Cites Trial Concerns in Rejection of Tabelecleucel for EBV+ PTLD",
  "description": "20260113T153000Z",
  "content": "",
  "source": "empr.com",
  "source_url": "https://www.empr.com/news/fda-cites-trial-concerns-in-rejection-of-tabelecleucel-for-ebv-ptld/",
  "published_at": "20260113T153000Z",
  "fetched_at": "2026-01-14T00:24:05.619157+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.empr.com/news/fda-cites-trial-concerns-in-rejection-of-tabelecleucel-for-ebv-ptld/",
    "url_mobile": "",
    "title": "FDA Cites Trial Concerns in Rejection of Tabelecleucel for EBV+ PTLD",
    "seendate": "20260113T153000Z",
    "socialimage": "https://www.empr.com/wp-content/uploads/sites/7/2024/01/MPR_1200x675.png",
    "domain": "empr.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}